{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T06:54:00Z","timestamp":1679295240682},"reference-count":9,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["mol clin onc"],"DOI":"10.3892\/mco.2019.1805","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T10:22:56Z","timestamp":1548238976000},"source":"Crossref","is-referenced-by-count":5,"title":["Pembrolizumab in newly diagnosed EBV\u2011negative extranodal natural killer\/T\u2011cell lymphoma: A case report"],"prefix":"10.3892","author":[{"given":"Samia","family":"Asif","sequence":"first","affiliation":[{"name":"Department of Hematological Malignancies, Saint-Luke's Cancer Institute\/University of Missouri School of Medicine, Kansas City, MO 64111, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline","family":"Begemann","sequence":"additional","affiliation":[{"name":"Department of Hematological Malignancies, Saint-Luke's Cancer Institute\/University of Missouri School of Medicine, Kansas City, MO 64111, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Hematological Malignancies, Saint-Luke's Cancer Institute\/University of Missouri School of Medicine, Kansas City, MO 64111, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawish","family":"Fatima","sequence":"additional","affiliation":[{"name":"Department of Hematological Malignancies, Saint-Luke's Cancer Institute\/University of Missouri School of Medicine, Kansas City, MO 64111, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashiq","family":"Masood","sequence":"additional","affiliation":[{"name":"Rush University Medical Center, Chicago, IL 60612, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzad","family":"Raza","sequence":"additional","affiliation":[{"name":"Department of Hematological Malignancies, Saint-Luke's Cancer Institute\/University of Missouri School of Medicine, Kansas City, MO 64111, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"key20200713202324_b1-mco-0-0-1805","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1309\/AJCP7YLTQPUSDQ5C","article-title":"Distribution of lymphoid neoplasms in China: Analysis of 4,638 cases according to the World Health Organization classification","volume":"138","author":"Sun","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"key20200713202324_b2-mco-0-0-1805","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume":"10","author":"Tse","year":"2017","journal-title":"J Hematol Oncol"},{"key":"key20200713202324_b3-mco-0-0-1805","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/PAS.0000000000000735","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: Clinical, pathologic, and genetic features","volume":"41","author":"Nicolae","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"key20200713202324_b4-mco-0-0-1805","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/modpathol.2017.37","article-title":"EBV-negative aggressive NK-cell leukemia\/lymphoma: A clinical and pathological study from a single institution","volume":"30","author":"Gao","year":"2017","journal-title":"Mod Pathol"},{"key":"key20200713202324_b5-mco-0-0-1805","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1182\/blood-2017-07-796342","article-title":"Immune evasion via PD-1\/PD-L1 on NK cells and monocyte\/macrophages is more prominent in Hodgkin lymphoma than DLBCL","volume":"131","author":"Vari","year":"2018","journal-title":"Blood"},{"key":"key20200713202324_b6-mco-0-0-1805","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1182\/blood-2016-12-756841","article-title":"PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK\/T-cell lymphoma failing l-asparaginase","volume":"129","author":"Kwong","year":"2017","journal-title":"Blood"},{"key":"key20200713202324_b7-mco-0-0-1805","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1158\/1078-0432.CCR-16-0153","article-title":"DDGP versus SMILE in newly diagnosed advanced natural killer\/T-cell lymphoma: A randomized controlled, multicenter, open-label study in China","volume":"22","author":"Li","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20200713202324_b8-mco-0-0-1805","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13045-018-0559-7","article-title":"Activity of pembrolizumab in relapsed\/refractory NK\/T-cell lymphoma","volume":"11","author":"Li","year":"2018","journal-title":"J Hematol Oncol"},{"key":"key20200713202324_b9-mco-0-0-1805","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13045-018-0647-8","article-title":"Abscopal effect of radiotherapy combined with immune checkpoint inhibitors","volume":"11","author":"Liu","year":"2018","journal-title":"J Hematol Oncol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:23:26Z","timestamp":1594668206000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2019.1805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":9,"URL":"https:\/\/doi.org\/10.3892\/mco.2019.1805","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]}}}